Descovy is not approved for preexposure prophylaxis (PrEP) in females because early studies did not test its effectiveness in preventing HIV from vaginal sex. Later research suggests it’s not more ...
Taking Descovy with ibuprofen or another NSAID can increase the risk of kidney damage (a side effect of Descovy). But there are no reported interactions between Descovy and acetaminophen (Tylenol).
Clock’s ticking. After an expected FDA nod for Descovy as the second HIV PrEP drug, Gilead Sciences now has one year to convince its current Truvada takers to switch over before generics hit. The FDA ...
Descovy demonstrated continued noninferiority to Truvada for HIV pre-exposure prophylaxis and statistically significant differences over Truvada for pre-specified secondary end points. In the phase 3, ...
The FDA has approved Gilead’s combination drug Descovy for HIV prophylaxis in the US, offering a way of cutting the risk of sexually acquired infection with an improved safety profile compared with ...
Gilead announced positive results from Phase 3 studies which switched virologically suppressed HIV-1 patients from regimens containing Truvada (emtricitabine and tenofovir disoproxil fumarate ...
Gilead Sciences, after striking a similar deal in 2014 to delay generics of its earlier HIV pre-exposure prophylaxis (PrEP) med Truvada, has followed suit on its key next-gen offering Descovy. Monday, ...
(Reuters) - The U.S. Food and Drug Administration on Thursday approved Gilead Sciences Inc's <GILD.O> Descovy to reduce the risk of sexually acquired HIV infection in men and transgender women who ...
Add Yahoo as a preferred source to see more of our stories on Google. A major health insurer has notified policy holders that it will no longer cover Gilead Sciences’ drug Descovy for pre-exposure ...
George Froehle, PA, a primary care clinician at CentraCare in rural St. Cloud, Minnesota, has been prescribing the HIV prevention pill tenofovir disoproxil fumarate plus emtracitabine (TDF/FTC) since ...
With Gift Aid, your generous donation of £10 would be worth £12.50 at no extra cost to you. Yes, I want to Gift Aid any donations made to NAM now, in the future and in the past four years I am a UK ...
Gilead Sciences, the drug giant behind the blockbuster HIV prevention pill Truvada, won FDA approval on Thursday to market Descovy — a medication already used by those who have HIV — as its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results